Skip to main content
Top
Published in: BMC Nephrology 1/2016

Open Access 01-12-2016 | Research article

Kidney epithelium specific deletion of kelch-like ECH-associated protein 1 (Keap1) causes hydronephrosis in mice

Authors: Sanjeev Noel, Lois J. Arend, Samatha Bandapalle, Sekhar P. Reddy, Hamid Rabb

Published in: BMC Nephrology | Issue 1/2016

Login to get access

Abstract

Background

Transcription factor Nrf2 protects from experimental acute kidney injury (AKI) and is promising to limit progression in human chronic kidney disease (CKD) by upregulating multiple antioxidant genes. We recently demonstrated that deletion of Keap1, the endogenous inhibitor of Nrf2, in T lymphocytes significantly protects from AKI. In this study, we investigated the effect of Keap1 deletion on Nrf2 mediated antioxidant response in the renal tubular epithelial cells.

Methods

We deleted Keap1 exon 2 and 3 in the renal tubular epithelial cells by crossing Ksp-Cre mice with Keap1 floxed (Keap1 f/f) mice. Deletion of Keap1 gene in the kidney epithelial cells of Ksp-Keap1 -/- mice and its effect on Nrf2 target gene expression was performed using PCR and real-time PCR respectively. Histological evaluation was performed on H&E stained sections. Complete blood count, serum and urine analysis were performed to assess systemic effects of defective kidney development. Student’s T test was used to determine statistical difference between the groups.

Results

Ksp-Cre resulted in the deletion of Keap1 exon 2 and 3 and subsequent upregulation of Nrf2 target genes, Nqo1, Gclm and Gclc in the kidney epithelial cells of Ksp-Keap1 -/- mice at baseline. Renal epithelial cell specific deletion of Keap1 in Ksp-Keap1 -/- mice caused marked renal pelvic expansion and significant compression of medullary parenchyma consistent with hydronephrosis in both (3 month-old) males and females. Kidneys from 6 month-old Ksp-Keap1 -/- mice showed progressive hydronephrosis. Hematological, biochemical and urinary analysis showed significantly higher red blood cell count (p = 0.04), hemoglobin (p = 0.01), hematocrit (p = 0.02), mean cell volume (p = 0.02) and mean cell hemoglobin concentration (p = 0.003) in Ksp-Keap1 -/- mice in comparison to Keap1 f/f mice.

Conclusions

These unexpected findings demonstrate that Keap1 deletion in renal tubular epithelial cells results in an abnormal kidney development consistent with hydronephrosis and reveals a novel Keap1 mediated signaling pathway in renal development.
Literature
1.
go back to reference Liu M, Grigoryev DN, Crow MT, Haas M, Yamamoto M, Reddy SP, et al. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int. 2009;76:277–85.CrossRefPubMed Liu M, Grigoryev DN, Crow MT, Haas M, Yamamoto M, Reddy SP, et al. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int. 2009;76:277–85.CrossRefPubMed
2.
go back to reference Liu M, Reddy NM, Higbee EM, Potteti HR, Noel S, Racusen L, et al. The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice. Kidney Int. 2014;85:134–41.CrossRefPubMed Liu M, Reddy NM, Higbee EM, Potteti HR, Noel S, Racusen L, et al. The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice. Kidney Int. 2014;85:134–41.CrossRefPubMed
3.
go back to reference Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89–116.CrossRefPubMed Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89–116.CrossRefPubMed
4.
go back to reference Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76–86.CrossRefPubMedPubMedCentral Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76–86.CrossRefPubMedPubMedCentral
5.
go back to reference Baird L, Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol. 2011;85:241–72.CrossRefPubMed Baird L, Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol. 2011;85:241–72.CrossRefPubMed
6.
go back to reference Shelton LM, Park BK, Copple IM. Role of Nrf2 in protection against acute kidney injury. Kidney Int. 2013;84:1090–5.CrossRefPubMed Shelton LM, Park BK, Copple IM. Role of Nrf2 in protection against acute kidney injury. Kidney Int. 2013;84:1090–5.CrossRefPubMed
7.
go back to reference Tanaka Y, Maher JM, Chen C, Klaassen CD. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Mol Pharmacol. 2007;71:817–25.CrossRefPubMed Tanaka Y, Maher JM, Chen C, Klaassen CD. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Mol Pharmacol. 2007;71:817–25.CrossRefPubMed
8.
go back to reference Li M, Liu RM, Timblin CR, Meyer SG, Mossman BT, Fukagawa NK. Age affects ERK1/2 and Nrf2 signaling in the regulation of GCLC expression. J Cell Physiol. 2006;206:518–25.CrossRefPubMed Li M, Liu RM, Timblin CR, Meyer SG, Mossman BT, Fukagawa NK. Age affects ERK1/2 and Nrf2 signaling in the regulation of GCLC expression. J Cell Physiol. 2006;206:518–25.CrossRefPubMed
9.
go back to reference Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S, et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet. 2003;35:238–45.CrossRefPubMed Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S, et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet. 2003;35:238–45.CrossRefPubMed
10.
go back to reference Kong X, Thimmulappa R, Craciun F, Harvey C, Singh A, Kombairaju P, et al. Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. Am J Respir Crit Care Med. 2011;184:928–38.CrossRefPubMedPubMedCentral Kong X, Thimmulappa R, Craciun F, Harvey C, Singh A, Kombairaju P, et al. Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis. Am J Respir Crit Care Med. 2011;184:928–38.CrossRefPubMedPubMedCentral
11.
go back to reference Noel S, Martina MN, Bandapalle S, Racusen LC, Potteti HR, Hamad ARA, et al. T lymphocyte-specific activation of Nrf2 protects from AKI. J Am Soc Nephrol. 2015;26:2989–3000.CrossRefPubMed Noel S, Martina MN, Bandapalle S, Racusen LC, Potteti HR, Hamad ARA, et al. T lymphocyte-specific activation of Nrf2 protects from AKI. J Am Soc Nephrol. 2015;26:2989–3000.CrossRefPubMed
12.
go back to reference Blake DJ, Singh A, Kombairaju P, Malhotra D, Mariani TJ, Tuder RM, et al. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. Am J Respir Cell Mol Biol. 2010;42:524–36.CrossRefPubMed Blake DJ, Singh A, Kombairaju P, Malhotra D, Mariani TJ, Tuder RM, et al. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. Am J Respir Cell Mol Biol. 2010;42:524–36.CrossRefPubMed
13.
go back to reference Shao X, Somlo S, Igarashi P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol. 2002;13:1837–46.CrossRefPubMed Shao X, Somlo S, Igarashi P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol. 2002;13:1837–46.CrossRefPubMed
14.
go back to reference Zhang Z, Pascuet E, Hueber PA, Chu L, Bichet DG, Lee TC, et al. Targeted inactivation of EGF receptor inhibits renal collecting duct development and function. J Am Soc Nephrol. 2010;21:573–8.CrossRefPubMedPubMedCentral Zhang Z, Pascuet E, Hueber PA, Chu L, Bichet DG, Lee TC, et al. Targeted inactivation of EGF receptor inhibits renal collecting duct development and function. J Am Soc Nephrol. 2010;21:573–8.CrossRefPubMedPubMedCentral
15.
go back to reference Fujita H, Hamazaki Y, Noda Y, Oshima M, Minato N. Claudin-4 deficiency results in urothelial hyperplasia and lethal hydronephrosis. PLoS One. 2012;7(12):e52272.CrossRefPubMedPubMedCentral Fujita H, Hamazaki Y, Noda Y, Oshima M, Minato N. Claudin-4 deficiency results in urothelial hyperplasia and lethal hydronephrosis. PLoS One. 2012;7(12):e52272.CrossRefPubMedPubMedCentral
16.
go back to reference Iizuka-Kogo A, Akiyama T, Senda T. Decreased apoptosis and persistence of the common nephric duct during the development of an aberrant vesicoureteral junction in Dlg1 genetargeted mice. Anat Rec (Hoboken). 2013;296:1936–42.CrossRef Iizuka-Kogo A, Akiyama T, Senda T. Decreased apoptosis and persistence of the common nephric duct during the development of an aberrant vesicoureteral junction in Dlg1 genetargeted mice. Anat Rec (Hoboken). 2013;296:1936–42.CrossRef
17.
go back to reference Chen CP, Chang SD, Wang TH, Wang LK, Tsai JD, Liu YP, et al. Detection of recurrent transmission of 17q12 microdeletion by array comparative genomic hybridization in a fetus with prenatally diagnosed hydronephrosis, hydroureter, and multicystic kidney, and variable clinical spectrum in the family. Taiwan J Obstet Gynecol. 2013;52:551–7.CrossRefPubMed Chen CP, Chang SD, Wang TH, Wang LK, Tsai JD, Liu YP, et al. Detection of recurrent transmission of 17q12 microdeletion by array comparative genomic hybridization in a fetus with prenatally diagnosed hydronephrosis, hydroureter, and multicystic kidney, and variable clinical spectrum in the family. Taiwan J Obstet Gynecol. 2013;52:551–7.CrossRefPubMed
18.
go back to reference Stark S, Winkelmann B, Kluthe C, Roigas J, Querfeld U, Müller D. Polycythemia and increased erythropoietin in a patient with chronic kidney disease. Nat Clin Pract Nephrol. 2007;3:222–6.CrossRefPubMed Stark S, Winkelmann B, Kluthe C, Roigas J, Querfeld U, Müller D. Polycythemia and increased erythropoietin in a patient with chronic kidney disease. Nat Clin Pract Nephrol. 2007;3:222–6.CrossRefPubMed
19.
go back to reference Toyama K, Mitus WJ. Experimental renal erythrocytosis. 3. Relationship between the degree of hydronephrotic pressure and the production of erythrocytosis. J Lab Clin Med. 1966;68:740–52.PubMed Toyama K, Mitus WJ. Experimental renal erythrocytosis. 3. Relationship between the degree of hydronephrotic pressure and the production of erythrocytosis. J Lab Clin Med. 1966;68:740–52.PubMed
20.
go back to reference Fisher JW, Schofield R, Porteous DD. Effects of renal hypoxia on erythropoietin production. Br J Haematol. 1965;11:382–8.CrossRefPubMed Fisher JW, Schofield R, Porteous DD. Effects of renal hypoxia on erythropoietin production. Br J Haematol. 1965;11:382–8.CrossRefPubMed
21.
go back to reference Eckardt KU, Kurtz A. Regulation of erythropoietin production. Eur J Clin Invest. 2005;35 Suppl 3:13–9.CrossRefPubMed Eckardt KU, Kurtz A. Regulation of erythropoietin production. Eur J Clin Invest. 2005;35 Suppl 3:13–9.CrossRefPubMed
22.
go back to reference Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependentproteolysis. Nature. 1999;399:271–5.CrossRefPubMed Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependentproteolysis. Nature. 1999;399:271–5.CrossRefPubMed
Metadata
Title
Kidney epithelium specific deletion of kelch-like ECH-associated protein 1 (Keap1) causes hydronephrosis in mice
Authors
Sanjeev Noel
Lois J. Arend
Samatha Bandapalle
Sekhar P. Reddy
Hamid Rabb
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0310-y

Other articles of this Issue 1/2016

BMC Nephrology 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.